β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights (1) π’ Company Q&A (475) π οΈ Industry Q&A (100) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ€ Insider Trades
| Date | Type | Name | A/D | Amount | Price | Security |
|---|---|---|---|---|---|---|
| 2025-04-03 | M-Exempt | Bohnen Shane officer: SVP - General Counsel |
D | 2260 | Restricted Stock Units | |
| 2025-02-14 | M-Exempt | Herr Amy E. director |
D | 1976 | 44.33 | Stock Option (Right to Buy) |
| 2025-02-03 | A-Award | Herr Amy E. director |
A | 115 | Restricted Stock Units | |
| 2025-02-01 | Herr Amy E. director |
480 | Restricted Stock Units | |||
| 2025-02-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-02-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-01-27 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2024-11-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2024-11-01 | ***** | ***** |
***** | ***** | ***** | ***** |
ποΈ Explore more insider trade data for Bio-Techne!
Sign up for free or log inπ₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"